Ole Isacson
Corporate Officer/Principal en Harvard Medical School .
Fortuna: 387 $ al 31/03/2024
Perfil
Ole Isacson is currently the Director of the Neuroregeneration Institute at McLean Hospital, a Professor at Harvard Medical School, and a Member of the Harvard Stem Cell Institute.
He previously served as the Chief Scientific Officer and SVP of Neuroscience R&D at Pfizer Inc. and as the President of the Neural Transplantation and Repair division of the American Society for Neurological Therapeutics.
He was also the President of the International Cell division of the Transplantation Society.
Isacson holds undergraduate and doctorate degrees from the University of Lund.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 15/06/2023 | 121 ( 0.00% ) | 387 $ | 31/03/2024 |
Cargos activos de Ole Isacson
| Empresas | Cargo | Inicio |
|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | 01/01/2002 |
McLean Hospital, Inc.
 McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Corporate Officer/Principal | 01/01/2010 |
Harvard Stem Cell Institute
 Harvard Stem Cell Institute BiotechnologyHealth Technology Harvard Stem Cell Institute provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists. The company was founded by Doug A. Melton and David T. Scadden in April 2004 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Ole Isacson.
| Empresas | Cargo | Fin |
|---|---|---|
| CYCLERION THERAPEUTICS, INC. | Director/Board Member | 19/11/2023 |
| PFIZER, INC. | Chief Tech/Sci/R&D Officer | 01/05/2017 |
| Transplantation Society | Corporate Officer/Principal | - |
| American Society For Neurological Therapeutics | Corporate Officer/Principal | - |
Formación de Ole Isacson.
| University of Lund | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| CYCLERION THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 4 |
|---|---|
| Transplantation Society | |
McLean Hospital, Inc.
McLean Hospital, Inc. Hospital/Nursing ManagementHealth Services McLean Hospital, Inc. provides healthcare services. It offers specialized programs for the research and treatment of psychiatric and neurological illnesses, including: depression, bipolar and psychotic disorders, mood and anxiety disorders, substance abuse, geriatric mental illnesses and child adolescent psychiatric disorders. The company was founded in February, 1811 and is headquartered in Belmont, MA. | Health Services |
Harvard Stem Cell Institute
Harvard Stem Cell Institute BiotechnologyHealth Technology Harvard Stem Cell Institute provides research regarding stem cells necessary for the understanding of human development and disease and trains next generation stem cell scientists. The company was founded by Doug A. Melton and David T. Scadden in April 2004 and is headquartered in Cambridge, MA. | Health Technology |
| American Society For Neurological Therapeutics |
- Bolsa de valores
- Insiders
- Ole Isacson
